Peripheral Perfusion
11
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
9.1%
1 terminated out of 11 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
DiCART TM Device for Capillary Refill Time Measurement
Capillary Refill Index with Rewarming
Radial Artery Cannulation and Perfusion Index
Modified Allen's Test and Peripheral Perfusion Index
Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries
Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients
Peripheral and Mesenteric Perfusion in Elective Surgical Patients
Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock
Topical Salve for Skin Oxygenation and Blood Flow
Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study
Assessment of Peripheral Perfusion in the Critically Ill Patient